Jayashri Pawar, MD serves as Medical Director at Nucs AI, where she leads the company’s vision and AI strategy to advance precision imaging in prostate cancer and oncology care. She brings deep clinical insight to the responsible development and deployment of AI technologies, ensuring accuracy, quality, and meaningful impact on patient outcomes. With more than 15 years of experience in diagnostic medical imaging, Dr. Pawar has broad expertise across molecular imaging, CT, MRI, ultrasound, and emergency radiology, paired with hands-on leadership in building and scaling AI/ML and generative AI solutions in healthcare.
Previously, she served as Medical Director of Clinical AI at Covera Health, helping shape enterprise AI strategy and supporting national deployment of computer vision, NLP, and GenAI models for radiology quality and population health. She completed a Clinical Innovation Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital’s Center for Clinical Data Science, advancing AI solutions toward FDA clearance and clinical adoption.
Dr. Pawar is also an active member of the Point-of-Care Ultrasound (POCUS) community and is committed to bridging clinical practice, innovation, and AI leadership to help define the future of imaging-driven care.
The non-responder gap matters for two reasons: First, patients who are in an advanced stage of cancer lose valuable time in ineffective therapy. Second, it increases the cost of therapy and resources for both patients and the broader healthcare ecosystem.